1-N-Boc-3-Pyrrolidinone, 99.0%, 5g

Nitrate de strontium, min 99 %, pa, ACS, 100 g, emballage plastique.

2'-C-Methylcytidine, 95.0%, 1g

1H-Pyrrolo[3,2-b]pyridin-3-amine, 98%, 1g

2-(3-Tolyl)-4-(2-hydroxyphenyl)thiazole, 1g

Ethyl 2-(3-formyl-4-hydroxyphenyl)-4-methylthiazole-5-carboxylate, 95.0%, 100g

2-(2,3-Dioxo-2,3-dihydro-indol-1-yl)-acetamide, 95.0%, 100mg

4'-bromo-3-(4-bromophenyl)propiophenone, 95.0%, 1g

H-ASN(MTT)-OH, 97.0%, 5g

(R)-2-(((Benzyloxy)carbonyl)amino)hexanoic acid, 95.0%, 100g

4-CHLOROTHIENO[2,3-C]PYRIDINE-2-CARBOXYLIC ACID METHYL ESTER, 97%, 1g

N'-Hydroxyoxane-4-carboximidamide, 1g

Ethyl 2-(4-formyl-2-nitrophenoxy)acetate, 95+%, 250mg